Time-kill kinetics of quinupristin/dalfopristin on Staphylococcus aureus with and without a raised MBC evaluated by two methods

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue SUPPL. A, 1997, Pages 29-32

  Boswell, F J ^a   Sunderland, J ^a   Andrews, J M ^a   Wise, R ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN; QUINUPRISTIN; STREPTOGRAMIN DERIVATIVE;

ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; SURVIVAL;

EID: 0030927287     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.suppl_1.29     Document Type: Article

References (10)

1. Barrière, J. C., Bouanchaud, D. H., Paris, J. M., Robin, O., Harris, N. V. & Smith, C. (1992). Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 1-8.
2. Aumercier, M., Bouhallab, S., Capmau, M.-L. & LeGoffic, F. (1992). RP 59500: a proposed mechanism for its bactericidal activity. Journal of Antimicrobial Chemotherapy 30, Suppl. A, 9-14.
3. Andrews, J. M. & Wise, R. (1994). The in-vitro activity of a new semisynthetic streptogramin compound RP 59500, against staphylococci and respiratory pathogens. Journal of Antimicrobial Chemotherapy 33, 849-53.
4. National Committee for Clinical Laboratory Standards. (1992). Methods for Determining Bactericidal Activity of Antimicrobial Agents; Tentative Guideline. NCCLS Document. NCCLS, Villanova, PA.
5. Barrière, J. C., Bouanchaud, D. H., Desnottes, J. F. & Paris, J. M. (1994). Streptogramin analogues. Expert Opinion on Investigational Drugs 3, 115-31.
6. Pepper, K. & Bouanchaud, D. H. (1996). In vitro activity of quinupristin/dalfopristin (RP 59500) against Gram-positive pathogens: an update. Expert Opinion on Investigational Drugs 5, 357-63.
7. Boswell, F. J., Andrews, J. M. & Wise, R. (1994). The postantibiotic effect of RP 59500 on Staphylococcus aureus including strains with a raised MBC. Journal of Antimicrobial Chemotherapy 33, 1219-22.
8. Crumplin, G. C., Kenwright, M. & Hirst, T. (1984). Investigations into the mechanisms of action of the antimicrobial agent norfloxacin. Journal of Antimicrobial Chemotherapy 13, Suppl. B, 9-23.
9. Fantin, B. (1995). Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristindalfopristin) in experimental endocarditis due to Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 39, 400-5.
10. Fantin, B., Leclercq, R., Merle, Y., Saint-Julien, L., Duval, J. & Carbon, C. (1994). Influence of constitutive resistance to erythromycin on the activity of RP 59500 (quinupristin/dalfopristin) in experimental endocarditis due to Staphylococcus aureus. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, 1994, Abstract B79, p. 150. American Society for Microbiology, Washington, DC.